Synergy effects of copper ion in doxorubicin-based chelate prodrug for cancer chemo-chemodynamic combination therapy

References

• Badrooh M, Shokrollahi F, Javan S, et al. (2022). Trigger of apoptosis in adenocarcinoma gastric cell line (AGS) by a complex of thiosemicarbazone and copper nanoparticles. Mol Biol Rep 49:1–14.
   PubMed Web of Science ®Google Scholar
• Cagel M, Moretton MA, Bernabeu E, et al. (2020). Antitumor efficacy and cardiotoxic effect of doxorubicin-loaded mixed micelles in 4T1 murine breast cancer model. comparative studies using Doxil® and free doxorubicin. J Drug Delivery Sci Technol 56:101506.
   Web of Science ®Google Scholar
• Chen C, Tan Y, Xu T, et al. (2022). Sorafenib-loaded copper peroxide nanoparticles with redox balance disrupting capacity for enhanced chemodynamic therapy against tumor cells. Langmuir 38:12307–15.
   PubMed Web of Science ®Google Scholar
• Cheong A, McGrath S, Robinson T, et al. (2021). A switch in mechanism of action prevents doxorubicin-mediated cardiac damage. Biochem Pharmacol 185:114410.
   PubMed Web of Science ®Google Scholar
• Jin M, Kong L, Han Y, Zhang S. (2021). Gut microbiota enhances the chemosensitivity of hepatocellular carcinoma to 5-fluorouracil in vivo by increasing curcumin bioavailability. Phytother Res 35:5823–37.
   PubMed Web of Science ®Google Scholar
• Kheirolomoom A, Mahakian LM, Lai C-Y, et al. (2010). Copper − doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity. Mol Pharm 7:1948–58.
   PubMed Web of Science ®Google Scholar
• Kim BS, Park I-H, Lee A-H, et al. (2022). Sacubitril/Valsartan reduces endoplasmic reticulum stress in a rat model of doxorubicin-induced cardiotoxicity. Arch Toxicol 96:1065–74.
   PubMed Web of Science ®Google Scholar
• Kratz F. (2007). DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials. Expert Opin Investig Drugs 16:855–66.
   PubMed Web of Science ®Google Scholar
• Li J, Hu Z-E, We Y-J, et al. (2022). Multifunctional carbon quantum dots as a theranostic nanomedicine for fluorescence imaging-guided glutathione depletion to improve chemodynamic therapy. J Colloid Interface Sci 606:1219–28.
   PubMed Web of Science ®Google Scholar
• Li J, Liu P. (2022). Facile fabrication of cupric ion-carbon quantum dots as tumor-specific nanotheranostics for cuprous ion-mediated chemodynamic therapy and real-time fluorescence imaging. Mater Today Chem 26:101040.
   Web of Science ®Google Scholar
• Li X, Huo F, Zhang Y, et al. (2022). Enzyme-activated prodrugs and their release mechanisms for the treatment of cancer. J Mater Chem B 10:5504–19.
   PubMed Web of Science ®Google Scholar
• Li X, Luo R, Liang X, et al. (2022). Recent advances in enhancing reactive oxygen species based chemodynamic therapy. Chin Chem Lett 33:2213–30.
   Web of Science ®Google Scholar
• Li Z, Zhou L, Qin Y, et al. (2023). Mangasese doped polypyrole nanoparticels for photothermal/chemodynamic therapy and immune activation. Nanotechnology 34:055102.
   Web of Science ®Google Scholar
• Lin C, Tao Y, Saw PE, et al. (2019). A polyprodrug-based nanoplatform for cisplatin prodrug delivery and combination cancer therapy. Chem Commun (Camb) 55:13987–90.
   PubMed Web of Science ®Google Scholar
• Llovet JM, De Baere T, Kulik L, et al. (2021). Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 18:293–313.
   PubMed Web of Science ®Google Scholar
• Luerken L, Haimerl M, Doppler M, et al. (2022). Update on percutaneous local ablative procedures for the treatment of hepatocellular carcinoma. Rofo 194:1075–86.
   PubMedGoogle Scholar
• Mashreghi M, Faal Maleki M, Karimi M, et al. (2021). Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-P32 CGKRK peptide. J Drug Target 29:617–30.
   PubMed Web of Science ®Google Scholar
• Mo Y, Wu Y, Li X, et al. (2020). Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation. Eur J Pharmacol 867:172788.
   PubMed Web of Science ®Google Scholar
• Mohamed AA, Abo-Amer YE-E, Aalkhalegy A, et al. (2021). COL1A1 gene expression in hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) Egyptian’s patients. TOBIOMJ 11:108–14.
   Google Scholar
• Nakajima M, Tokumitsu Y, Shindo Y, et al. (2021). The recent development of the surgical treatment for hepatocellular carcinoma. Appl Sci 11:2023.
   Google Scholar
• Oyama A, Nouso K, Yoshimura K, et al. (2021). Randomized controlled study to examine the efficacy of hepatic arterial infusion chemotherapy with cisplatin before radiofrequency ablation for hepatocellular carcinoma. Hepatol Res 51:694–701.
   PubMed Web of Science ®Google Scholar
• Pereira-Oliveira M, Reis-Mendes A, Carvalho F, et al. (2019). Doxorubicin is key for the cardiotoxicity of FAC (5-fluorouracil + adriamycin + cyclophosphamide) combination in differentiated H9c2 Cells. Biomolecules 9:21.
   PubMedGoogle Scholar
• Pho-Iam T, Punnakitikashem P, Somboonyosdech C, et al. (2021). PLGA nanoparticles containing α-fetoprotein SiRNA induce apoptosis and enhance the cytotoxic effects of doxorubicin in human liver cancer cell line. Biochem Biophys Res Commun 553:191–7.
   PubMed Web of Science ®Google Scholar
• Phuengkham H, Song C, Lim YT. (2019). A designer scaffold with immune nanoconverters for reverting immunosuppression and enhancing immune checkpoint blockade therapy. Adv Mater 31:e1903242.
   PubMed Web of Science ®Google Scholar
• Qiu X, Li Z, Wu Y, et al. (2022). Core-coordinated elliptic polymer nanoparticles loading copper(II) and chlorambucil for cooperative chemodynamic/chemotherapy. Biomacromolecules 23:4519–31.
   PubMedGoogle Scholar
• Singh M, Nicol AT, DelPozzo J, et al. (2022). Demystifying the relationship between metformin, AMPK, and doxorubicin cardiotoxicity. Front Cardiovasc Med 9:839644.
   PubMed Web of Science ®Google Scholar
• Su M, Zhu Y, Chen J, et al. (2022). Microfluidic synthesis of manganese-alginate nanogels with self-supplying H2O2 capability for synergistic chemo/chemodynamic therapy and boosting anticancer immunity. Chem Eng J 435:134926.
   Web of Science ®Google Scholar
• Tan H, Zhang M, Wang Y, et al. (2022). Innovative nanochemotherapy for overcoming cancer multidrug resistance. Nanotechnology 33:052001.
   Web of Science ®Google Scholar
• Tang Z, Liu Y, He M, Bu W. (2019). Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions. Angew Chem Int Ed Engl 58:946–56.
   PubMed Web of Science ®Google Scholar
• Tang Z, Zhao P, Wang H, et al. (2021). Biomedicine meets fenton chemistry. Chem Rev 121:1981–2019.
   PubMed Web of Science ®Google Scholar
• Wang C, Xue F, Wang M, et al. (2022). 2D Cu-bipyridine MOF nanosheet as an agent for colon cancer therapy: a three-in-one approach for enhancing chemodynamic therapy. ACS Appl Mater Interfaces 14:38604–16.
   PubMedGoogle Scholar
• Wang C-I, Chu P-M, Chen Y-L, et al. (2021). Chemotherapeutic drug-regulated cytokines might influence therapeutic efficacy in HCC. IJMS 22:13627.
   Google Scholar
• Wang S, Tian R, Zhang X, et al. (2021). Beyond photo: Xdynamic therapies in fighting Cancer. Adv Mater 33:2007488.
   Web of Science ®Google Scholar
• Wang S, Yu G, Wang Z, et al. (2019). Enhanced antitumor efficacy by a cascade of reactive oxygen species generation and drug release. Angew Chem Int Ed Engl 58:14758–63.
   PubMed Web of Science ®Google Scholar
• Xin Y, Guo Z, Ma A, et al. (2023). A robust ROS generation nanoplatform combating periodontitis via sonodynamic/chemodynamic combination therapy. Chem Eng J 451:138782.
   Web of Science ®Google Scholar
• Xu Y, Xiao L, Chen J, et al. (2022). α-Fe2O3 based nanotherapeutics for near-infrared/dihydroartemisinin dual-augmented chemodynamic antibacterial therapy. Acta Biomater 150:367–79.
   PubMed Web of Science ®Google Scholar
• Yang Y, Xin Y, Ye F, et al. (2021). Early recurrence after radiofrequency ablation for hepatocellular carcinoma: a multicenter retrospective study on definition, patterns and risk factors. Int J Hyperthermia 38:437–46.
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhang L, Wei J, et al. (2022). Tumor acidity-activatable photothermal/fenton nanoagent for synergistic therapy. J Colloid Interface Sci 612:355–66.
   PubMed Web of Science ®Google Scholar
• Yu H, Ma M, Liang K, et al. (2021). A self-assembled metal-polyphenolic nanomedicine for mild photothermal-potentiated chemodynamic therapy of tumors. Appl Mater Today 25:101235.
   Web of Science ®Google Scholar
• Yu Z, Thompson Z, Behnke SL, et al. (2020). Metalloglycosidase mimics: oxidative cleavage of saccharides promoted by multinuclear copper complexes under physiological conditions. Inorg Chem 59:11218–22.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhou X, Zhang H, et al. (2022). Recent progress of novel nanotechnology challenging the multidrug resistance of cancer. Front Pharmacol 13:776895.
   PubMed Web of Science ®Google Scholar
• Zhang H, Han R, Song P, et al. (2023). Hydrogen peroxide self-sufficient and glutathione-depleted nanoplatform for boosting chemodynamic therapy synergetic phototherapy. J Colloid Interface Sci 629:103–13.
   PubMed Web of Science ®Google Scholar
• Zhao H, Zhao Y, Xu J, et al. (2020). Programmable co-assembly of various drugs with temperature sensitive nanogels for optimizing combination chemotherapy. Chem Eng J 398:125614.
   Web of Science ®Google Scholar
• Zheng T, Wang J, Song X, et al. (2021). Correction to: nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma Cells through P53 or P73 signaling pathways. J Cancer Res Clin Oncol 147:3457–8.
   PubMed Web of Science ®Google Scholar
• Zhou K, Huo X, Nguyen R, et al. (2022). Aptamer-mediated doxorubicin delivery reduces HCC burden in 3D organoids model. J Control Release 341:341–50.
   PubMed Web of Science ®Google Scholar
• Zhou K, Zhang Z, Xue J, et al. (2022). Hybrid Ag nanoparticles/polyoxometalate-polydopamine nano-flowers loaded chitosan/gelatin hydrogel scaffolds with synergistic photothermal/chemodynamic/Ag + anti-bacterial action for accelerated wound healing. Int J Biol Macromol 221:135–48.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Tong F, Gu W, et al. (2022). Co-delivery of photosensitizer and diclofenac through sequentially responsive bilirubin nanocarriers for combating hypoxic tumors. Acta Pharm Sin B 12:1416–31.
   PubMed Web of Science ®Google Scholar